Who has invested in TauRx Pharmaceuticals?

Genting are named among the investors backing TauRx Pharmaceuticals.

TauRx Pharmaceuticals Funding: $300M Raised, Series E (2022)

TauRx Pharmaceuticals funding overview

TauRx Pharmaceuticals is based in Singapore. TauRx Pharmaceuticals has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series E announced in November 2022. The round record for TauRx Pharmaceuticals runs through 2022; nothing later has been disclosed. Investors on record include Genting.

TauRx Pharmaceuticals at a glance

Total raised: $300M
Latest round: Series E
Latest round date: November 2022
Headquarters: Singapore
Notable investors: Genting

Frequently asked about TauRx Pharmaceuticals funding

How much has TauRx Pharmaceuticals raised?: TauRx Pharmaceuticals has raised $300M in total disclosed funding across the rounds on record.
Who has invested in TauRx Pharmaceuticals?: Genting are named among the investors backing TauRx Pharmaceuticals.
What was the latest TauRx Pharmaceuticals funding round?: The most recent disclosed round is a Series E, announced in November 2022.
Where is TauRx Pharmaceuticals based?: TauRx Pharmaceuticals is based in Singapore.
When did TauRx Pharmaceuticals last raise?: The last disclosed TauRx Pharmaceuticals round closed in November 2022 at Series E.

Every TauRx Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Singapore at a similar stage.

TauRx Pharmaceuticals Funding: $300M Raised, Series E (2022)

TauRx Pharmaceuticals funding overview

TauRx Pharmaceuticals at a glance

Frequently asked about TauRx Pharmaceuticals funding

Companies related to TauRx Pharmaceuticals (18)

Browse related funding lists (5)